AAL

Options Traders Should Consider This Hot Drug Stock

SAGE options are attractively priced

Managing Editor
Jan 2, 2018 at 12:29 PM
facebook X logo linkedin


SAGE Therapeutics Inc (NASDAQ:SAGE) had a rip-roaring end to 2017, tacking on 78% in December, and touching an all-time high of $173.36 on Dec. 8. It appears the momentum might spill over into 2018, with the drug stock sending up a signal to buy short-term options right now.

While SAGE stock vaulted up the charts, its short-term options prices remained in the proverbial basement. The equity's Schaeffer's Volatility Index (SVI) of 79% is higher than just 9% of all others from the past year, pointing to relatively attractive short-term premiums amid muted volatility expectations.

The last time SAGE Therapeutics stock was flirting with 52-week highs and sported a low SVI, the shares went on to rally one month later, according to data from Schaeffer's Senior Quantitative Analyst Rocky White. Specifically, SAGE stock averaged a one-month gain of 11.95% after its last signal of this type. A similar surge from current levels would place the shares around $182, a record high.

Today, the biotech stock is down a quiet 0.5% to trade at $163.88. The equity has tacked on an impressive 222% over the last 52-weeks, riding an early December bull-gap following upbeat drug trial results its depression drug.

A short squeeze could provide more fuel for the SAGE's run. Short interest increased by 24.7% during the last two reporting periods to 4.01 million shares, the highest point since mid-September. This represents a healthy 12% of SAGE's total available float. 

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.